Friday, Oct 23, 2026
Focus on the big picture

FDA Panel Approves Pfizer's Covid Shot for Kids Age 5-11

Bloomberg, 29 Oct 2021
The benefits of a Covid-19 vaccine for young children made by Pfizer Inc. and BioNTech SE exceed its risks, according to a panel of U.S. experts. Bloomberg's ...
Related Articles